Become A Featured Company

WeedMD Gains Traction After Going Public

Ryan Allway

May 17th, 2017

News, Top Story

WeedMD Inc. (TSXV: WMD) soared from less than C$0.30 to more than C$1.00 after going public through a reverse merger transaction (raised capital last at C$0.60). After securing a sales license from Health Canada, the company is well-positioned to capitalize on Canada’s burgeoning cannabis industry as recreational legalization is poised to go into effect early next year. Still, the stock has a market capitalization of just C$60 million, which makes it a bargain compared to many other LPs.

In this article, we will take a closer look at the company and why investors may want to consider taking a position in the stock.

Unique Approach

WeedMD aims to capitalize on the senior care segment of the cannabis industry through its outreach into long-term care and assisted living facilities. There are more than 460,000 Canadian residents living in these facilities, while that figure is expected to double by 2031 as the population ages. In fact, the senior population grew by 3.5% last year, which is four times faster than the general population, which makes for a compelling end market.

About 60% of seniors in long-term care facilities take more than ten medications per day, with 16% of them taking pain medications known as opioids. Opioids are closely associated with addiction and other adverse health effects, while medical cannabis has been shown to treat many of these conditions and dramatically improve quality of life. Cannabis is also much more cost-effective than prescription pharmaceuticals like opioids.

WeedMD’s management team has over 100 years of combined experience in public, senior management, and ownership roles within the senior care industry. With a deep understanding of the industry’s challenges, the company aims to position itself as a key strategic partner and help improve the quality of life of these patients. The patient population is also very ‘sticky’ with regular consumption, which offers cost and operational efficiencies.

Growing Cultivation Footprint

WeedMD has a license to cultivate within its 26,000 square foot former Imperial Tobacco facility and already has 14,000 square feet under lights. In the future, the company plans to expand to over 220,000 square feet that will include grow rooms and an extraction lab. The existing facility also sits on over four acres of land in Ontario with an option to acquire another four, and further potential for expansion on a nearby 100-acre parcel.

On April 28, the company secured a sales license from Health Canada for dried cannabis products from its Ontario facility. In addition, the company was licensed to start selling materials to patients that wish to grow their own medicine under the ACMPR, a practice that the company strongly supports. These products will appear on the company’s website as soon as they are available, which means revenue generation in the near-term.

“Obtaining our license to sell dried cannabis products is another major milestone for WeedMD,” said CEO Bruce Dawson-Scully in a recent press release. “The expedited nature of the sales amendment came ahead of schedule and accelerates our timeline to revenue generation and is a direct result of the dedication and quality efforts of our entire team. We look forward to opening our doors to patients and are excited to serve both patients in the long-term care and senior markets as well as the broader medical patient community.”

Looking Ahead

WeedMD Inc. (TSXV: WMD) represents a promising investment opportunity within Canada’s burgeoning cannabis industry. With an existing production facility that licensed to sell, the company is well-positioned to begin generating near-term revenue. Management’s experience in the senior care market could translate to significant long-term opportunities given the favorable patient demographics and growth rates over the coming years.

For more information, visit the company’s website at www.weedmd.com.

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.

Network Partners

Follow Us on Social Media

LinkedIn

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading